Related references
Note: Only part of the references are listed.Multidimensional endotypes of chronic rhinosinusitis and their association with treatment outcomes
B. Liao et al.
ALLERGY (2018)
Nasal polyposis pathophysiology: Endotype and phenotype open issues
Giuseppe Brescia et al.
AMERICAN JOURNAL OF OTOLARYNGOLOGY (2018)
Nasal IL-25 predicts the response to oral corticosteroids in chronic rhinosinusitis with nasal polyps
Haiyu Hong et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Local IL-25 contributes to Th2-biased inflammatory profiles in nasal polyps
H-Y. Hong et al.
ALLERGY (2018)
The role of IL-25 and IL-33 in chronic rhinosinusitis with or without nasal polyps
Atakan Ozturan et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2017)
Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
Claus Bachert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
New fronts emerge in the influenza cytokine storm
Xi-zhi J. Guo et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Chronic Rhinosinusitis with Polyps Is Characterized by Increased Mucosal and Blood Th17 Effector Cytokine Producing Cells
Dijana Miljkovic et al.
FRONTIERS IN PHYSIOLOGY (2017)
Targeting IL-25 as a novel therapy in chronic rhinosinusitis with nasal polyps
Mingyu Lee et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Epidermal growth factor receptor signalling regulates granulocyte-macrophage colony-stimulating factor production by airway epithelial cells and established allergic airway disease
T. H. Acciani et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2016)
Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis A Randomized Clinical Trial
Claus Bachert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
IL-25/IL-33-responsive TH2 cells characterize nasal polyps with a default TH17 signature in nasal mucosa
Emily P. S. Lam et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Release of Type 2 Cytokines by Epithelial Cells of Nasal Polyps
Monica Boita et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Increased IL-21 expression in chronic rhinosinusitis with nasalpolyps
L. Xiao et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2015)
IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis
Hyun-Woo Shin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
Mario Castro et al.
LANCET RESPIRATORY MEDICINE (2015)
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Hector G. Ortega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Increased expression of IL-19 in the epithelium of patients with chronic rhinosinusitis and nasal polyps
E. Pace et al.
ALLERGY (2012)
Fine PM induce airway MUC5AC expression through the autocrine effect of amphiregulin
Stephanie Val et al.
ARCHIVES OF TOXICOLOGY (2012)
EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists
Wytske J. Fokkens et al.
RHINOLOGY (2012)
Functional Specialization of Interleukin-17 Family Members
Yoichiro Iwakura et al.
IMMUNITY (2011)
Increased Expression and Role of Thymic Stromal Lymphopoietin in Nasal Polyposis
Satoko Kimura et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2011)
Interleukin-19: Multiple roles in immune regulation and disease
Grant Gallagher
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Tissue remodeling induced by hypersecreted epidermal growth factor and amphiregulin in the airway after an acute asthma attack
Yukinori Enomoto et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease
Nan Zhang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Endoscopic and quadity-of-life outcomes after, revision endoscopic sinus surgery
Jamie R. Litvack et al.
LARYNGOSCOPE (2007)
Clinical outcomes after endoscopic sinus surgery
Neil Bhattacharyya
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2006)
FcεRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells
S Okumura et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
IL-25 induces IL-4 IL-5, and IL-13 and Th2-associated pathologies in vivo
MM Fort et al.
IMMUNITY (2001)
Share Paper
